Table 4 Identification of rare diseases by emergency physicians
Rare Diseases, n (%) | Total (n = 218) | CME Training Group (n = 108) | Non-training Group (n = 110) |
|---|---|---|---|
Idiopathic pulmonary arterial hypertension | 47 (21.6) | 26 (24.1) | 21 (19.1) |
Idiopathic pulmonary fibrosis | 37 (17.0) | 20 (18.5) | 17 (15.5) |
IgG4-related disease | 90 (41.3) | 45 (41.7) | 45 (40.9) |
Lymphangioleiomyomatosis | 70 (32.1) | 39 (36.1) | 31 (28.2) |
Marfan syndrome | 92 (42.2) | 39 (36.1) | 53 (48.2) |
Multiple sclerosis | 43 (19.7) | 23 (21.3) | 20 (18.2) |
Multiple myeloma | 21 (9.6) | 11 (10.2) | 10 (9.1) |
POEMS syndrome | 105 (48.2) | 56 (51.9) | 49 (44.5) |
Porphyria with SIADH | 119 (54.6) | 63 (58.3) | 56 (50.9) |
Atypical hemolytic uremic syndrome | 58 (26.6) | 32 (29.6) | 26 (23.6) |
Autoimmune encephalitis | 44 (20.2) | 18 (16.7) | 26 (23.6) |
Systemic lupus erythematosus | 10 (4.6) | 3 (2.8) | 7 (6.4) |
Castleman disease | 102 (46.8) | 58 (53.7) | 54 (49.1) |
Generalized myasthenia gravis | 33 (15.1) | 15 (13.9) | 18 (16.4) |
Acromegaly | 27 (12.4) | 16 (14.8) | 11 (10.0) |
Hemophilia | 29 (13.3) | 15 (13.9) | 14 (12.7) |
Hepatolenticular degeneration | 88 (40.4) | 48 (44.4) | 40 (36.4) |
Alveolar proteinosis | 74 (33.9) | 44 (40.7) | 30 (27.3) |
Langerhans cell histiocytosis | 105 (48.2) | 56 (51.9) | 49 (44.5) |